Skip to main content

Journals in Cellular biology

Acta Histochemica

  • ISSN: 0065-1281
  • 5 Year impact factor: 2.3
  • Impact factor: 2.3
Research and Methods in Cell and Tissue BiologyActa Histochemica is a classic scientific journal established in 1954 currently focused on basic research and methodological innovations in cell and tissue biology. The aim of the journal is to promote the peer-reviewed publication of original articles and short communications reporting novel results and experimental approaches in the field, as well as comprehensive reviews, letters to the editor and meeting reports, serving as an open forum for the cell and histochemical research community. Manuscripts analysing the mechanisms of functional regulation of living systems at a cell/tissue level, in physiological or pathological conditions, or reporting new techniques and methodological approaches to quantify/visualize cellular activities are particularly welcomed.
Acta Histochemica

Ageing Research Reviews

  • ISSN: 1568-1637
  • 5 Year impact factor: 13
  • Impact factor: 12.5
As the average human life expectancy has increased, so too has the impact of ageing and age-related disease on our society. Ageing research is now the focus of thousands of laboratories that include leaders in the areas of genetics, molecular and cellular biology, biochemistry, and behaviour. Ageing Research Reviews (ARR) covers the trends in this field. It is designed to fill a large void, namely, a source for critical reviews and viewpoints on emerging findings on mechanisms of ageing and age-related disease. Rapid advances in understanding of mechanisms that control cellular proliferation, differentiation and survival are leading to new insight into the regulation of ageing. From telomerase to stem cells to energy and oxyradical metabolism, this is an exciting new era in the multidisciplinary field of ageing research. The cellular and molecular underpinnings of manipulations that extend lifespan, such as caloric restriction, are being identified and novel approaches for preventing age-related diseases are being developed. ARR publishes articles on focussed topics selected from the broad field of ageing research, with an emphasis on cellular and molecular mechanisms of the aging process and age-related diseases such as cancer, cardiovascular disease, diabetes and neurodegenerative disorders. Applications of basic ageing research to lifespan extension and disease prevention are also covered in this journal.
Ageing Research Reviews

Biochimica et Biophysica Acta: Molecular Cell Research

  • ISSN: 0167-4889
  • 5 Year impact factor: 4.9
  • Impact factor: 4.6
BBA Molecular Cell Research focuses on understanding the mechanisms of cellular processes at the molecular level. These include aspects of cellular signaling, signal transduction, cell cycle, apoptosis, intracellular trafficking, secretory and endocytic pathways, biogenesis of cell organelles, cytoskeletal structures, cellular interactions, cell/tissue differentiation and cellular enzymology. Also included are studies at the interface between Cell Biology and Biophysics which apply, for example, novel imaging methods for characterizing cellular processes.Please note: We usually do not consider descriptive manuscripts dealing with the identification of transcripts regulated by single miRNAs or lncRNAs, unless substantial new mechanistic insight into their (patho)physiological activity is provided. Descriptive evaluation of natural compounds as potential drug candidates are generally not within the purview of BBA-MCR, unless novel targets or molecular mechanisms for these compounds are identified.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center
Biochimica et Biophysica Acta: Molecular Cell Research

Biologicals

  • ISSN: 1045-1056
  • 5 Year impact factor: 1.6
  • Impact factor: 1.5
Official Journal of the International Alliance for Biological StandardizationBiologicals provides a modern and multidisciplinary international forum for the publication of research that advances the development, manufacturing, quality control, standardization, safety, efficacy, and regulatory aspects of human and veterinary biological products derived from both novel and established biotechnologies. Special issues are produced to reflect topics of particular international interest and concern. Three types of papers are welcome: original research reports, short papers, and review articles. The journal will also publish comments and letters to the editor, book reviews, meeting reports and information on regulatory issues.Research Areas IncludeAreas relevant to biologicals for human and veterinary use such as:• Bacterial vaccines • Blood products • Cell biology • Cell culture technology • Cellular immunology • Cytokines and allied mediators • Diagnostics • Downstream processing • Gene transfer and expression • General bacteriology • General virology, endogenous and adventitious viruses • Hormones • Immunochemistry • Molecular biology • Monoclonal antibodies • Parasitology • Prion and prion disease • Protein chemistry • Toxins • Toxoids • Viral vaccines
Biologicals

Bone

  • ISSN: 8756-3282
  • 5 Year impact factor: 3.8
  • Impact factor: 3.5
BONE is an interdisciplinary forum for the rapid publication of original articles and reviews on basic, translational, and clinical aspects of bone and mineral metabolism, including rare bone diseases. The Journal also encourages submissions related to interactions of bone with other organ systems, including cartilage, tendon and other connective tissues, endocrine, muscle, fat, neural, vascular, gastrointestinal, hematopoietic, and immune systems. Particular attention is placed on the application of artificial intelligence and experimental studies to clinical practice.US National Institutes of Health (NIH) voluntary posting ("Public Access") policy.BONE and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authors.Original research articles and case reports can also be submitted to BONE's Gold Open Access companion title, Bone Reports.
Bone

Cancer Cell

  • ISSN: 1535-6108
  • 5 Year impact factor: 42.1
  • Impact factor: 48.8
Cancer Cell provides a high-profile forum to promote major advances in cancer research and oncology. The primary criterion for considering manuscripts is whether the studies provide major advances into answering important questions relevant to naturally occurring cancers. Cancer Cell particularly welcomes translational research.Cancer Cell is also interested in publishing clinical investigations, in particular those that lead to establishing new paradigms in the treatment, diagnosis, or prevention of cancers; those that provide important insights into cancer biology beyond what has been revealed by preclinical studies; and those that are mechanism-based proof-of-principle clinical studies.Visit the Cell Press website for more information about Cancer Cell - http://www.cell.com/Cancer-Cell/home
Cancer Cell

Cancer Genetics

  • ISSN: 0165-4608
  • 5 Year impact factor: 1.7
  • Impact factor: 1.4
The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterCancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
Cancer Genetics

Cancer Genetics

  • ISSN: 2210-7762
  • 5 Year impact factor: 1.7
  • Impact factor: 1.4
The aim of Cancer Genetics is to publish high quality scientific papers on the cellular, genetic and molecular aspects of cancer, including cancer predisposition and clinical diagnostic applications. Specific areas of interest include descriptions of new chromosomal, molecular or epigenetic alterations in benign and malignant diseases; novel laboratory approaches for identification and characterization of chromosomal rearrangements or genomic alterations in cancer cells; correlation of genetic changes with pathology and clinical presentation; and the molecular genetics of cancer predisposition. To reach a basic science and clinical multidisciplinary audience, we welcome original full-length articles, reviews, meeting summaries, brief reports, and letters to the editor.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support CenterCancer Genetics is proud to be affiliated with the Cancer Genomics Consortium.
Cancer Genetics

Cardiovascular Pathology

  • ISSN: 1054-8807
  • 5 Year impact factor: 2
  • Impact factor: 2.3
A Journal of Basic, Clinical and Applied Cardiovascular Science The Official Journal of the Society for Cardiovascular PathologyCardiovascular Pathology is a bimonthly journal that presents articles on topics covering the entire spectrum of cardiovascular disease. The Journal's primary objective is to publish papers on disease-oriented morphology and pathogenesis from clinicians and scientists in the cardiovascular field. Subjects covered include cardiovascular biology, prosthetic devices, molecular biology and experimental models of cardiovascular disease.For more information about the Society for Cardiovascular Pathology (SCVP), please visit their website at URL: http://scvp.net .Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com
Cardiovascular Pathology

Cell

  • ISSN: 0092-8674
  • 5 Year impact factor: 49
  • Impact factor: 45.5
Cell publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. The basic criterion for considering papers is whether the results provide significant conceptual advances into, or raise provocative questions and hypotheses regarding, an interesting and important biological question. In addition to primary research articles in four formats, Cell features review and opinion articles on recent research advances and issues of interest to its broad readership in the leading edge section.Visit the Cell Press website for more information about Cell - http://www.cell.com/cell/home
Cell